201 related articles for article (PubMed ID: 10370678)
1. Intra-arterial versus systemic chemotherapy for non-operable hepatocellular carcinoma.
Tzoracoleftherakis EE; Spiliotis JD; Kyriakopoulou T; Kakkos SK
Hepatogastroenterology; 1999; 46(26):1122-5. PubMed ID: 10370678
[TBL] [Abstract][Full Text] [Related]
2. A comparative randomized trial of intermittent intrahepatic arterial carboplatin- versus doxorubicin-lipiodol emulsion in advanced hepatocellular carcinoma (stage IV).
Homma H; Mezawa S; Doi T; Miyanishi K; Takada K; Kukitsu T; Oku T; Masuko E; Nojiri S; Niitsu Y
Hepatogastroenterology; 2004; 51(58):1135-9. PubMed ID: 15239261
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of repeated percutaneous isolated liver chemoperfusion in local control of unresectable hepatocellular carcinoma.
Ku Y; Tominaga M; Iwasaki T; Fukumoto T; Muramatsu S; Kusunoki N; Sugimoto T; Suzuki Y; Kuroda Y; Saitoh Y
Hepatogastroenterology; 1998; 45(24):1961-5. PubMed ID: 9951848
[TBL] [Abstract][Full Text] [Related]
4. [Study of intra-arterial infusion chemotherapy for hepatocellular carcinoma using an implantable reservoir].
Maruo H; Kosaka A
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1473-6. PubMed ID: 8396899
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for advanced hepatocellular carcinoma: systemic chemotherapy or hepatic arterial infusion chemotherapy?
Yamashita T
J Gastroenterol; 2004; 39(4):404-6. PubMed ID: 15168258
[No Abstract] [Full Text] [Related]
6. [Chemotherapy of hepatocellular carcinoma--with special reference to one-shot intra-arterial infusion of a high dose of adriamycin].
Hirose H; Aoyama M; Oshima K; Udo K; Kobayashi S; Adachi N; Nonaka T; Yamada T
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2216-21. PubMed ID: 6307182
[TBL] [Abstract][Full Text] [Related]
7. [Intra-arterial administration of epirubicin in the treatment of non-resectable hepatocellular carcinoma. Epirubicin Study Group for Hepatocellular Carcinoma].
Nagasue N; Yukaya H; Okamura J; Kuroda C; Kubo Y; Hirai K; Tanikawa K; Okita K; Ando K; Tamura K
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2786-92. PubMed ID: 3019251
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
Wen J; Shen WL; Yang SH
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
[TBL] [Abstract][Full Text] [Related]
9. Influence of the etiology of liver cirrhosis on the response to combined intra-arterial chemotherapy in patients with advanced hepatocellular carcinoma.
Kanayama M; Nagai H; Sumino Y
Cancer Chemother Pharmacol; 2009 Jun; 64(1):109-14. PubMed ID: 18979100
[TBL] [Abstract][Full Text] [Related]
10. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
[TBL] [Abstract][Full Text] [Related]
11. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].
Lim TY; Cheong JY; Cho SW; Sim SJ; Kim JS; Choi SJ; Choi JW; Kwon HC; Lee KM; Kim JK; Won JH; Yoo BM; Lee KJ; Hahm KB; Kim JH
Korean J Hepatol; 2006 Mar; 12(1):65-73. PubMed ID: 16565607
[TBL] [Abstract][Full Text] [Related]
12. Intra-arterial infusion chemotherapy on unresectable hepatocellular carcinoma under occlusion of hepatic arterial flow.
Une Y; Uchino J; Yasuhara M; Misawa K; Kamiyama T; Shimamura T; Sato N; Nakajima Y; Hata Y
Clin Ther; 1993; 15(2):347-54. PubMed ID: 8390917
[TBL] [Abstract][Full Text] [Related]
13. [Studies on postoperative arterial infusion chemotherapy using implanted reservoir for hepatocellular carcinoma].
Nagabuchi E; Une Y; Nakajima Y; Matsuoka S; Kamiyama T; Gotoda A; Saito M; Nagasako Y; Uchino J
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1837-41. PubMed ID: 1652223
[TBL] [Abstract][Full Text] [Related]
14. Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumors.
Ku Y; Fukumoto T; Tominaga M; Iwasaki T; Maeda I; Kusunoki N; Obara H; Sako M; Suzuki Y; Kuroda Y; Saitoh Y
Am J Surg; 1997 Feb; 173(2):103-9. PubMed ID: 9074373
[TBL] [Abstract][Full Text] [Related]
15. Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin.
Gish RG; Porta C; Lazar L; Ruff P; Feld R; Croitoru A; Feun L; Jeziorski K; Leighton J; Gallo J; Kennealey GT
J Clin Oncol; 2007 Jul; 25(21):3069-75. PubMed ID: 17634485
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
[TBL] [Abstract][Full Text] [Related]
17. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma by placing a temporary catheter via the subclavian route.
Liang HL; Huang JS; Lin YH; Lai KH; Yang CF; Pan HB
Acta Radiol; 2007 Sep; 48(7):734-40. PubMed ID: 17729003
[TBL] [Abstract][Full Text] [Related]
18. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
[TBL] [Abstract][Full Text] [Related]
19. [Adjuvant hepatic arterial chemotherapy on hepatocellular carcinoma with THP-adriamycin and carboplatin].
Misawa K; Une Y; Kamiyama T; Nakajima Y; Sato N; Matsushita M; Shimamura T; Masuko Y; Yasuhara M; Uchino J
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1477-80. PubMed ID: 8396900
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma.
Lu YS; Hsu C; Li CC; Kuo SH; Yeh KH; Yang CH; Hsu CH; Wu CY; Cheng AL
Hepatogastroenterology; 2004; 51(57):815-9. PubMed ID: 15143923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
